FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fernando Rizzello

Research Profile

Disorders

Living Beings

Concepts & Ideas

Anatomy

Intestinal Mucosa

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
A Agostini; Francesca Benuzzi; A Bertani; Carlo Calabrese; Massimo Campieri; Mauro Ercolani; V Farinelli; N Filippini; Paolo Gionchetti; C Marchetta; Fernando Rizzello; A Scarcelli; Paolo Nichelli
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study.
Antonio Strillacci; Maria Chiara Valerii; Laura Vittori; Cinzia Caggiano; Massimo Campieri; Michelangelo Fiorentino; Gilberto Poggioli; Fernando Rizzello; Pasquale Sansone; Annamaria Sgromo; Enzo Spisni
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells.
Paolo Gionchetti; Silvio Laureti; Gilberto Poggioli; C Pratico; A Calafiore; Massimo Campieri; G Vitali; Fernando Rizzello
Randomized controlled trials in pouchitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fernando Rizzello (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A Agostini; Francesca Benuzzi; A Bertani; Carlo Calabrese; Massimo Campieri; Mauro Ercolani; V Farinelli; N Filippini; Paolo Gionchetti; C Marchetta; Fernando Rizzello; A Scarcelli; Paolo Nichelli
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2013;25(2):147-e82.
2013: Antonio Strillacci; Maria Chiara Valerii; Laura Vittori; Cinzia Caggiano; Massimo Campieri; Michelangelo Fiorentino; Gilberto Poggioli; Fernando Rizzello; Pasquale Sansone; Annamaria Sgromo; Enzo Spisni
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells.
The Journal of pathology 2013;229(3):379-89.
2012: Paolo Gionchetti; Silvio Laureti; Gilberto Poggioli; C Pratico; A Calafiore; Massimo Campieri; G Vitali; Fernando Rizzello
Randomized controlled trials in pouchitis.
Reviews on recent clinical trials 2012;7(4):303-6.
2011: Carlo Calabrese; Massimo Campieri; Massimo Derenzini; Paolo Gionchetti; Giuseppina Liguori; Lorenzo Montanaro; Fernando Rizzello; Elisa Brighenti; Manuela Vici; Davide Trerè
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease.
World journal of gastroenterology : WJG 2011;17(40):4496-502.
2011: Carlo Calabrese; Massimo Campieri; S Di Molfetta; Paolo Gionchetti; G Lazzarini; G Liguori; V Marzano; Fernando Rizzello; A Urbani; M C Valerii; Enzo Spisni
Distinct proteomic profiles characterise non-erosive from erosive reflux disease.
Alimentary pharmacology & therapeutics 2011;34(8):982-93.
2011: Alessandro Agostini; Carlo Calabrese; Raffaele Agati; Daniela Cevolani; Mauro Ercolani; Nicola Filippini; Paolo Gionchetti; Marco Leonardi; Chiara Leoni; Fernando Rizzello; Rosy Tambasco; Massimo Campieri
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing.
Inflammatory bowel diseases 2011;17(8):1769-77.
2011: Paolo Gionchetti; Carlo Calabrese; Rosy Tambasco; Ramona Brugnera; Giulia Straforini; Giuseppina Liguori; Giulia Spuri Fornarini; Donatella Riso; Massimo Campieri; Fernando Rizzello
Role of conventional therapies in the era of biological treatment in Crohn's disease.
World journal of gastroenterology : WJG 2011;17(14):1797-806.
2011: Livia Biancone; Carmelina Petruzziello; Ambrogio Orlando; A Kohn; Sandro Ardizzone; Marco Daperno; Erika Angelucci; Fabiana Castiglione; Renata D'Incà; Francesca Zorzi; Claudio Papi; Gianmichele Meucci; Gabriele Riegler; Giuseppe Sica; Fernando Rizzello; Filippo Mocciaro; Sara Onali; Emma Calabrese; Mario Cottone; Francesco Pallone
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study.
Inflammatory bowel diseases 2011;17(3):758-66.
2010: Antonio Strillacci; Cristiana Griffoni; G Lazzarini; M C Valerii; S Di Molfetta; Fernando Rizzello; Massimo Campieri; M P Moyer; Vittorio Tomasi; Enzo Spisni
Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells.
British journal of cancer 2010;103(7):975-86.
2010: Carlo Calabrese; Enzo Spisni; G Liguori; G Lazzarini; M C Valerii; Antonio Strillacci; Paolo Gionchetti; Uberto Pagotto; Massimo Campieri; Fernando Rizzello
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 2010;32(4):603-11.
2010: Alessandro Agostini; Fernando Rizzello; Gianni Ravegnani; Paolo Gionchetti; Rosy Tambasco; Giulia Straforini; Mauro Ercolani; Massimo Campieri
Adult attachment and early parental experiences in patients with Crohn's disease.
Psychosomatics 2010;51(3):208-15.
2010: Silvia Turroni; Beatrice Vitali; Marco Candela; Paolo Gionchetti; Fernando Rizzello; Massimo Campieri; Patrizia Brigidi
Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach.
World journal of gastroenterology : WJG 2010;16(1):30-41.
2010: Alessandro Agostini; Fernando Rizzello; Gianni Ravegnani; Paolo Gionchetti; Rosy Tambasco; Mauro Ercolani; Massimo Campieri
Parental bonding and inflammatory bowel disease.
Psychosomatics 2010;51(1):14-21.
2009: Magda Monari; J Foschi; Carlo Calabrese; G Liguori; Giulio Di Febo; Fernando Rizzello; Paolo Gionchetti; Andrea Trinchero; Gian Paolo Serrazanetti
Implications of antioxidant enzymes in human gastric neoplasms.
International journal of molecular medicine 2009;24(5):693-700.
2009: Loris Pironi; Francesca Bonvicini; Paolo Gionchetti; Antonia D'Errico; Fernando Rizzello; Catia Corsini; Laura Foroni; Giorgio Gallinella
Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.
Journal of clinical microbiology 2009;47(5):1591-5.
2008: Paolo Gionchetti; Fernando Rizzello; Rosy Tambasco; G Straforini; Gilberto Poggioli; Carlo Calabrese; R Brugnera; Massimo Campieri
Which therapies are advisable in pouchitis?
Inflammatory bowel diseases 2008;14 Suppl 2():S241-2.
2008: Marco Candela; F Perna; P Carnevali; Beatrice Vitali; R Ciati; Paolo Gionchetti; Fernando Rizzello; Massimo Campieri; Patrizia Brigidi
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.
International journal of food microbiology 2008;125(3):286-92.
2008: Fernando Rizzello; Massimo Campieri; Rosy Tambasco; G Straforini; R Brugnera; G Poggioli; Paolo Gionchetti
Medical treatment and management of severe ulcerative colitis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2008;40 Suppl 2():S280-4.
2008: Carlo Calabrese; G Liguori; V Gabusi; Paolo Gionchetti; Fernando Rizzello; G Straforini; R Brugnera; Giulio Di Febo
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Alimentary pharmacology & therapeutics 2008;28(2):250-5.
2008: Carlo Calabrese; Paolo Gionchetti; Fernando Rizzello; G Liguori; V Gabusi; Rosy Tambasco; Gilberto Poggioli; Filippo Pierangeli; Massimo Campieri; Giulio Di Febo
Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.
Alimentary pharmacology & therapeutics 2008;27(9):759-64.
2007: Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Gilberto Poggioli; Rosy Tambasco; Carlo Calabrese; Patrizia Brigidi; Beatrice Vitali; Giulia Straforini; Massimo Campieri
High-dose probiotics for the treatment of active pouchitis.
Diseases of the colon and rectum 2007;50(12):2075-82; discussion 2082-4.
2007: Gilberto Poggioli; Silvio Laureti; Massimo Campieri; Filippo Pierangeli; Paolo Gionchetti; Federica Ugolini; Lorenzo Gentilini; Piero Bazzi; Fernando Rizzello; Maurizio Coscia
Infliximab in the treatment of Crohn's disease.
Therapeutics and clinical risk management 2007;3(2):301-8.
2007: Carlo Calabrese; Anna Fabbri; Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; G Liguori; Gilberto Poggioli; Massimo Campieri; Giulio Di Febo
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis.
Alimentary pharmacology & therapeutics 2007;25(11):1311-6.
2007: Paolo Gionchetti; Fernando Rizzello; Gilberto Poggioli; Filippo Pierangeli; Silvio Laureti; Claudia Morselli; Rosy Tambasco; Carlo Calabrese; Massimo Campieri
Oral budesonide in the treatment of chronic refractory pouchitis.
Alimentary pharmacology & therapeutics 2007;25(10):1231-6.
2007: Beatrice Passarini; Salvatore Domenico Infusino; Elena Barbieri; Elisa Varotti; Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Rosy Tambasco; Massimo Campieri
Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Dermatology (Basel, Switzerland) 2007;215(4):295-300.
2006: Ulf Helwig; Karen Lammers; Fernando Rizzello; Patrizia Brigidi; Verena Rohleder; Elisabetta Caramelli; Paolo Gionchetti; Jürgen Schrezenmeir; Ulrich R Foelsch; Stefan Schreiber; Massimo Campieri
Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.
World journal of gastroenterology : WJG 2006;12(37):5978-86.
2006: Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Rosy Tambasco; Massimo Campieri
Review article: aminosalicylates for distal colitis.
Alimentary pharmacology & therapeutics 2006;24 Suppl 3():41-4.
2006: Rita Golfieri; A Cappelli; Emanuela Giampalma; Fernando Rizzello; Paolo Gionchetti; Silvio Laureti; Gilberto Poggioli; Massimo Campieri
CT-guided percutaneous pelvic abscess drainage in Crohn's disease.
Techniques in coloproctology 2006;10(2):99-105.
2006: Paolo Gionchetti; Fernando Rizzello; Karen Lammers; Claudia Morselli; Lucia Sollazzi; Samuel Davies; Rosy Tambasco; Carlo Calabrese; Massimo Campieri
Antibiotics and probiotics in treatment of inflammatory bowel disease.
World journal of gastroenterology : WJG 2006;12(21):3306-13.
2006: Tanja Kühbacher; Stephan J Ott; Ulf Helwig; T Mimura; Fernando Rizzello; Brigitta Kleessen; Paolo Gionchetti; Michael Blaut; Massimo Campieri; Ulrich R Fölsch; M A Kamm; Stefan Schreiber
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.
Gut 2006;55(6):833-41.
2006: Livia Biancone; A Orlando; A Kohn; E Colombo; Raffaello Sostegni; Erika Angelucci; Fernando Rizzello; F Castiglione; L Benazzato; Claudio Papi; Gianmichele Meucci; Gabriele Riegler; Carmelina Petruzziello; Filippo Mocciaro; Alessandra Geremia; Emma Calabrese; Mario Cottone; Francesco Pallone
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study.
Gut 2006;55(2):228-33.
2006: Paolo Gionchetti; Fernando Rizzello; Karen Lammers; Claudia Morselli; Rosy Tambasco; Massimo Campieri
Antimicrobials in the management of inflammatory bowel disease.
Digestion 2006;73 Suppl 1():77-85.
2005: Karen Lammers; Sander Ouburg; Servaas A Morré; J B A Crusius; P Gionchett; Fernando Rizzello; Claudia Morselli; Elisabetta Caramelli; R Conte; Gilberto Poggioli; Massimo Campieri; Amado Salvador Peña
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis.
World journal of gastroenterology : WJG 2005;11(46):7323-9.
2005: Paolo Gionchetti; Karen Lammers; Fernando Rizzello; Massimo Campieri
VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics.
Gastroenterology clinics of North America 2005;34(3):499-513, ix-x.
2005: Ambrogio Orlando; Elena Colombo; A Kohn; Livia Biancone; Fernando Rizzello; Angelo Viscido; Raffaello Sostegni; L Benazzato; Fabiana Castiglione; Claudio Papi; Gianmichele Meucci; Gabriele Riegler; Filippo Mocciaro; Andrea Cassinotti; R Cosintino; Alessandra Geremia; Claudia Morselli; Erika Angelucci; Alessandro Lavagna; Antonio Rispo; Fabrizio Bossa; Daniela Scimeca; Mario Cottone
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2005;37(8):577-83.
2005: Paolo Gionchetti; Karen Lammers; Fernando Rizzello; Massimo Campieri
Probiotics and barrier function in colitis.
Gut 2005;54(7):898-900.
2005: Paolo Gionchetti; Fernando Rizzello; Gilberto Poggioli; Claudia Morselli; Karen Lammers; Massimo Campieri
Probiotic therapy to prevent pouchitis onset.
Diseases of the colon and rectum 2005;48(7):1493; author reply 1493-4.
2005: Karen Lammers; Athanasios Vergopoulos; Nina Babel; Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Elisabetta Caramelli; Michelangelo Fiorentino; Antonia D'Errico; Hans-Dieter Volk; Massimo Campieri
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.
Inflammatory bowel diseases 2005;11(5):447-54.
2005: Gilberto Poggioli; Silvio Laureti; Filippo Pierangeli; Fernando Rizzello; Federica Ugolini; Paolo Gionchetti; Massimo Campieri
Local injection of Infliximab for the treatment of perianal Crohn's disease.
Diseases of the colon and rectum 2005;48(4):768-74.
2005: Paolo Gionchetti; Agesilao D'Arienzo; Fernando Rizzello; Francesco Manguso; Roberto Maieron; Pier Enrico Lecis; Daniela Valpiani; Gaetano Iaquinto; Vito Annese; Antonio Balzano; Guido Varoli; Massimo Campieri
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.
Journal of clinical gastroenterology 2005;39(4):291-7.
2005: Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Rossella Romagnoli; Massimo Campieri
Management of inflammatory bowel disease: does rifaximin offer any promise?
Chemotherapy 2005;51 Suppl 1():96-102.
2004: Ailsa L Hart; Karen Lammers; Patrizia Brigidi; Beatrice Vitali; Fernando Rizzello; Paolo Gionchetti; Massimo Campieri; Michael A Kamm; Stella C Knight; Andrew J Stagg
Modulation of human dendritic cell phenotype and function by probiotic bacteria.
Gut 2004;53(11):1602-9.
2004: Paolo Gionchetti; Claudia Morselli; Fernando Rizzello; Rossella Romagnoli; Massimo Campieri; Gilberto Poggioli; Silvio Laureti; Federica Ugolini; Filippo Pierangeli
Management of pouch dysfunction or pouchitis with an ileoanal pouch.
Best practice & research. Clinical gastroenterology 2004;18(5):993-1006.
2004: Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Massimo Campieri
Review article: problematic proctitis and distal colitis.
Alimentary pharmacology & therapeutics 2004;20 Suppl 4():93-6.
2004: Ulf Helwig; Paolo Gionchetti; Fernando Rizzello; Karen Lammers; Tanja Kühbacher; Stefan Schreiber; Marco Baggiolini; Mariagrazia Uguccioni; Massimo Campieri
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue.
International journal of colorectal disease 2004;19(2):165-70.
2004: T Mimura; Fernando Rizzello; Ulf Helwig; Gilberto Poggioli; S Schreiber; I C Talbot; R J Nicholls; Paolo Gionchetti; Massimo Campieri; M A Kamm
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.
Gut 2004;53(1):108-14.
2003: Paolo Gionchetti; Cristina Amadini; Fernando Rizzello; Annamaria Venturi; Gilberto Poggioli; Massimo Campieri
Probiotics for the treatment of postoperative complications following intestinal surgery.
Best practice & research. Clinical gastroenterology 2003;17(5):821-31.
2003: Karen Lammers; Patrizia Brigidi; Beatrice Vitali; Paolo Gionchetti; Fernando Rizzello; Elisabetta Caramelli; Diego Matteuzzi; Massimo Campieri
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.
FEMS immunology and medical microbiology 2003;38(2):165-72.
2003: Massimo Campieri; S Adamo; Daniela Valpiani; Agesilao D'Arienzo; Giuseppe d'Albasio; M Pitzalis; P Cesari; Tino Casetti; Guido Castiglione; Fernando Rizzello; Francesco Manguso; Guido Varoli; Paolo Gionchetti
Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study.
Alimentary pharmacology & therapeutics 2003;17(12):1471-80.
2003: Fernando Rizzello; Paolo Gionchetti; Annamaria Venturi; Massimo Campieri
Review article: medical treatment of severe ulcerative colitis.
Alimentary pharmacology & therapeutics 2003;17 Suppl 2():7-10.
2003: Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Annamaria Venturi; Karen Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.
Gastroenterology 2003;124(5):1202-9.
2003: Paolo Gionchetti; Cristina Amadini; Fernando Rizzello; Annamaria Venturi; Gilberto Poggioli; Massimo Campieri
Diagnosis and treatment of pouchitis.
Best practice & research. Clinical gastroenterology 2003;17(1):75-87.
2003: Paolo Gionchetti; Fernando Rizzello; Flavio Habal; Claudia Morselli; Cristina Amadini; Rossella Romagnoli; Massimo Campieri
Standard treatment of ulcerative colitis.
Digestive diseases (Basel, Switzerland) 2003;21(2):157-67.
2003: Karen Lammers; G Innocenti; Annamaria Venturi; Fernando Rizzello; Ulf Helwig; Giampaolo Bianchi; L Pedrini; Gianfranco Di Nino; Paolo Gionchetti; Massimo Campieri
The effect of transient intestinal ischemia on inflammatory parameters.
International journal of colorectal disease 2003;18(1):78-85.
2002: Paolo Gionchetti; Cristina Amadini; Fernando Rizzello; Annamaria Venturi; V Palmonari; Claudia Morselli; Rossella Romagnoli; Massimo Campieri
Probiotics--role in inflammatory bowel disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2002;34 Suppl 2():S58-62.
2002: Fernando Rizzello; Paolo Gionchetti; Annamaria Venturi; Claudia Morselli; Massimo Campieri
Review article: the management of refractory Crohn's disease.
Alimentary pharmacology & therapeutics 2002;16 Suppl 4():40-7.
2002: Paolo Gionchetti; Cristina Amadini; Fernando Rizzello; Annamaria Venturi; Massimo Campieri
Review article: treatment of mild to moderate ulcerative colitis and pouchitis.
Alimentary pharmacology & therapeutics 2002;16 Suppl 4():13-9.
2002: Fernando Rizzello; Paolo Gionchetti; Annamaria Venturi; Cristina Amadini; Rossella Romagnoli; Massimo Campieri
Review article: monitoring activity in ulcerative colitis.
Alimentary pharmacology & therapeutics 2002;16 Suppl 4():3-6.
2002: Patrizia Brigidi; Erwin Frans M. Swennen; Fernando Rizzello; M Bozzolasco; Diego Matteuzzi
Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis.
Journal of chemotherapy (Florence, Italy) 2002;14(3):290-5.
2002: Fernando Rizzello; Paolo Gionchetti; Agesilao D'Arienzo; Francesco Manguso; Giovanni Di Matteo; Vito Annese; Daniela Valpiani; Tino Casetti; S Adamo; A Prada; Guido Castiglione; Guido Varoli; Massimo Campieri
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study.
Alimentary pharmacology & therapeutics 2002;16(6):1109-16.
2002: Karen Lammers; Ulf Helwig; Erwin Frans M. Swennen; Fernando Rizzello; Annamaria Venturi; Elisabetta Caramelli; Michael A Kamm; Patrizia Brigidi; Paolo Gionchetti; Massimo Campieri
Effect of probiotic strains on interleukin 8 production by HT29/19A cells.
The American journal of gastroenterology 2002;97(5):1182-6.
2002: T Mimura; Fernando Rizzello; Ulf Helwig; Gilberto Poggioli; S Schreiber; I C Talbot; R J Nicholls; Paolo Gionchetti; Massimo Campieri; M A Kamm
Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.
Alimentary pharmacology & therapeutics 2002;16(5):909-17.
2002: Paolo Gionchetti; Fernando Rizzello; Massimo Campieri
Probiotics in gastroenterology.
Current opinion in gastroenterology 2002;18(2):235-9.
2001: Fernando Rizzello; Paolo Gionchetti; Roberta Galeazzi; G Novelli; Daniela Valpiani; Agesilao D'Arienzo; Francesco Manguso; Guido Castiglione; Guido Varoli; Massimo Campieri
Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: a dose-finding study.
Advances in therapy 2001;18(6):261-71.
2001: Salvatore Ulisse; Paolo Gionchetti; S D'Alò; FP Russo; I Pesce; G Ricci; Fernando Rizzello; Ulf Helwig; Maria Grazia Cifone; Massimo Campieri; Claudio De Simone
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.
The American journal of gastroenterology 2001;96(9):2691-9.
2001: Paolo Gionchetti; Fernando Rizzello; Massimo Campieri
Probiotics and antibiotics in inflammatory bowel disease.
Current opinion in gastroenterology 2001;17(4):331-5.
2000: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; Patrizia Brigidi; Diego Matteuzzi; G Bazzocchi; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
Gastroenterology 2000;119(2):305-9.
2000: Ulf Helwig; Karen Lammers; Paolo Gionchetti; Fernando Rizzello; Massimo Campieri; Mariagrazia Uguccioni
MCP-3 in inflammatory bowel disease.
Gut 2000;47(1):155.
2000: Gilberto Poggioli; Silvio Laureti; L Stocchi; Massimo Campieri; Federica Ugolini; MariaCristina Salone; Paolo Gionchetti; O Lauriola; Fernando Rizzello
[Immediate and long-term results in ileoanastomosis with reservoir in 335 consecutive cases].
Chirurgia italiana 2000;52(3):215-22.
2000: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; Massimo Campieri
Probiotics in infective diarrhoea and inflammatory bowel diseases.
Journal of gastroenterology and hepatology 2000;15(5):489-93.
1999: Annamaria Venturi; Paolo Gionchetti; Fernando Rizzello; R Johansson; E Zucconi; Patrizia Brigidi; Diego Matteuzzi; Massimo Campieri
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.
Alimentary pharmacology & therapeutics 1999;13(8):1103-8.
1999: Mariagrazia Uguccioni; Paolo Gionchetti; D F Robbiani; Fernando Rizzello; S Peruzzo; Massimo Campieri; Marco Baggiolini
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.
The American journal of pathology 1999;155(2):331-6.
1999: Paolo Gionchetti; Fernando Rizzello; A Ferrieri; Annamaria Venturi; C Brignola; M Ferretti; S Peruzzo; Mario Miglioli; Massimo Campieri
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.
Digestive diseases and sciences 1999;44(6):1220-1.
1999: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; Federica Ugolini; M Rossi; Patrizia Brigidi; R Johansson; A Ferrieri; Gilberto Poggioli; Massimo Campieri
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
Alimentary pharmacology & therapeutics 1999;13(6):713-8.
1999: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; Federica Ugolini; M Rossi; Patrizia Brigidi; R Johansson; A Ferrieri; Gilberto Poggioli; Massimo Campieri
Review--antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach.
European review for medical and pharmacological sciences 1999;3(1):27-30.
1998: Fernando Rizzello; Paolo Gionchetti; Annamaria Venturi; M Ferretti; S Peruzzo; X Raspanti; M Picard; N Canova; Ernesto Palazzini; Massimo Campieri
Rifaximin systemic absorption in patients with ulcerative colitis.
European journal of clinical pharmacology 1998;54(1):91-3.
1998: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; M Ferretti; C Brignola; Mario Miglioli; Massimo Campieri
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.
Diseases of the colon and rectum 1998;41(1):93-7.
1997: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; C Brignola; M Ferretti; S Peruzzo; Massimo Campieri
Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
Alimentary pharmacology & therapeutics 1997;11(6):1053-7.
1997: M Ferretti; Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; P Stella; F Corti; J Mizrahi; Mario Miglioli; Massimo Campieri
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis.
Digestive diseases and sciences 1997;42(12):2606-11.
1997: Paolo Gionchetti; Annamaria Venturi; Fernando Rizzello; C Corbelli; Stefano Fanti; M Ferretti; Stefano Boschi; Mario Miglioli; Massimo Campieri
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis.
Alimentary pharmacology & therapeutics 1997;11(4):679-84.
1997: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; M Ferretti; C Brignola; S Peruzzo; C Belloli; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis.
Alimentary pharmacology & therapeutics 1997;11(4):673-8.
1997: Paolo Gionchetti; Maurizio Vecchi; Fernando Rizzello; M Ferretti; Carmen Calabresi; Annamaria Venturi; MB Bianchi; C Brignola; renato alberto sinico; Roberto de Franchis; Mario Miglioli; Massimo Campieri
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils.
Gut 1997;40(1):102-4.
1996: Paolo Gionchetti; Massimo Campieri; Annamaria Venturi; Fernando Rizzello; M Ferretti; C Brignola; Mario Miglioli
Systemic availability of 5-aminosalicylic acid: comparison of delayed release and an azo-bond preparation.
Alimentary pharmacology & therapeutics 1996;10(4):601-5.
1994: A Belluzzi; C Brignola; Massimo Campieri; E P Camporesi; Paolo Gionchetti; Fernando Rizzello; C Belloli; G De Simone; S Boschi; Mario Miglioli
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients.
Digestive diseases and sciences 1994;39(12):2589-94.
1994: A Belluzzi; C Brignola; Massimo Campieri; Paolo Gionchetti; Fernando Rizzello; S Boschi; S Cunanne; Mario Miglioli; L Barbara
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long-chain fatty acid composition in patients with Crohn's disease.
Alimentary pharmacology & therapeutics 1994;8(1):127-30.